Literature DB >> 2044919

Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy.

R Meier, K Gyr, A Scholer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2044919     DOI： 10.1016/0016-5085(91)90501-b

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

Review 1.  Pathogenesis and treatment of portal-systemic encephalopathy: an update.

Authors:  R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

2.  Benzodiazepine-like substances and hepatic encephalopathy : implications for treatment.

Authors:  J A Cossar; P C Hayes; R E O'Carroll
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

3.  Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake.

Authors:  P Perney; R F Butterworth; D D Mousseau; J Lavoie; P Fabbro-Peray; F Blanc; G P Layrargues
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.